FdaApplication
NDA 020326
Identifiers
- fda_app_no: NDA020326
Properties
| Property | Value |
|---|---|
| applicant_name | MEDIMMUNE ONCOLOGY INC |
| application_type | NDA |
| approval_date | 1993-12-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEUTREXIN | TRIMETREXATE GLUCURONATE | EQ 200MG BASE/VIAL | INJECTABLE;INJECTION |
| NEUTREXIN | TRIMETREXATE GLUCURONATE | EQ 25MG BASE/VIAL | INJECTABLE;INJECTION |
2 products